Patent Eligibility Guidance Update: Vanda memorandum

The USPTO has posted its memorandum to the examining corps following the Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals decision.  The memorandum is available [here].

The Federal Circuit decision is available [here].

The oral argument at the Federal Circuit is available below:

Comments are closed.